Literature DB >> 2684158

Synthesis of diacylglycerol de novo is responsible for permanent activation and down-regulation of protein kinase C in transformed cells.

V Chiarugi1, P Bruni, F Pasquali, L Magnelli, G Basi, M Ruggiero, M Farnararo.   

Abstract

We measured the synthesis of diacylglycerol de novo in normal NIH/3T3 fibroblasts and in cells transformed by ras, src, sis and abl oncogenes. Analysis of the incorporation of glucose-derived 14C into diacylglycerol indicated that neosynthesis of diacylglycerol was constitutively active in the transformed cell lines. Elevated levels of diacylglycerol and persistent activation/down-regulation of protein kinase C reduced the binding of phorbol dibutyrate to transformed cells. This phenomenon could be reversed by blocking the glycolytic pathway, thus indicating that neosynthesized diacylglycerol was responsible for persistent activation and down-regulation of protein kinase C. In transformed cells, protein kinase C activity could not be stimulated by the addition of diolein; however, inhibition of glycolysis restored the ability of transformed cells to respond to diolein. Taken together these data indicate that constitutive synthesis of diacylglycerol de novo is responsible for activation and down-regulation of protein kinase C in transformed cells, and it may play a role in altered mitogenic signalling.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684158     DOI: 10.1016/0006-291x(89)91532-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  NIH-3T3 cells transformed with a ras oncogene exhibit a protein kinase C-mediated inhibition of agonist-stimulated Ca2+ inflow.

Authors:  A J Polverino; B P Hughes; G J Barritt
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

Review 2.  Regulation of p53 by protein kinase C during multi-stage carcinogenesis.

Authors:  L Magnelli; V Chiarugi
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

3.  Correction of abnormal small intestinal cytosolic protein kinase C activity in streptozotocin-induced diabetes by insulin therapy.

Authors:  R K Wali; P K Dudeja; M J Bolt; M D Sitrin; T A Brasitus
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

4.  Hypertrophy of human embryonic stem cell-derived cardiomyocytes supported by positive feedback between Ca2+ and diacylglycerol signals.

Authors:  Christine Deisl; Michael Fine; Orson W Moe; Donald W Hilgemann
Journal:  Pflugers Arch       Date:  2019-06-28       Impact factor: 3.657

5.  Effects of staurosporine, K 252a and other structurally related protein kinase inhibitors on shape and locomotion of Walker carcinosarcoma cells.

Authors:  A Zimmermann; H Keller
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.